新克隆/RNA Pol II RPB5单克隆抗体/W0014

价格
¥5500.00
货号:W0014
浏览量:127
品牌:NeoClone
服务
全国联保
正品保证
正规发票
签订合同
商品描述
Details:
Tested Applications
WB
Target Information
RPB5 is a 27kDa subunit of yeast RNA polymerase II.
Product Format
Ascites
Alternate Names
DNA-directed RNA polymerases I, II, and III subunit RPABC1, PolR2E, RNA polymerases I, II, and III subunit ABC1, RPA7, RPC9
Clone
3Y11
Host
Mouse
Isotype
IgG1
Immunogen
Recombinant Protein
Epitope
Unknown
Relevance
DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Common component of RNA polymerases I, II and III which synthesize ribosomal RNA precursors, mRNA precursors and many functional non-coding RNAs, and small RNAs, such as 5S rRNA and tRNAs, respectively. Pol II is the central component of the basal RNA polymerase II transcription machinery. Pols are composed of mobile elements that move relative to each other. In Pol II, RPB5 is part of the lower jaw surrounding the central large cleft and thought to grab the incoming DNA template. Seems to be the major component in this process
Specificity
Yeast (Saccharomyces cerevisiae) RNA Pol II
Reported Reactivity
None
Reported Applications
Unknown
What's Happening at NeoClone Biotechnology You're probably wondering, "Now that BioLegend owns all your former catalog products, what the heck are you doing up there in Madison?" I'm glad you asked. We're still making great monoclonal antibodies, of course! NeoClone has been making custom murine antibodies via hybridoma technology for years. In fact, that's where our catalog came from in the first place! We decided that we needed to return our focus to custom projects, especially the really difficult targets that researchers had been bringing us all along. You know, the targets that other companies couldn't make due to problems with tolerance or toxicity or bizarre secondary structures. Then we decided to branch out into other methods of generating antibodies. We brought on new staff with years of experience in Antibody Phage Display and Camelid VHH antibodies. We've been upping our game in the Bioinformatics arena as well, giving us an edge in determining the best way to make YOUR antibody. Unlike other antibody development companies, we're not tied to one particular method. In the world of antibody development, one size does NOT fit all. So, you tell us what you want. We'll make sure we get it for you.